BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 11880102)

  • 1. The evolving landscape of monogenic nephrolithiasis and therapeutic innovations.
    Wu CW; Huang YR; Bodner D; Schumacher FR; Baum M; Hildebrandt F
    Nat Rev Urol; 2024 Apr; ():. PubMed ID: 38632353
    [No Abstract]   [Full Text] [Related]  

  • 2. Genes polymorphism as risk factor of recurrent urolithiasis: a systematic review and meta-analysis.
    Rasyid N; Soedarman S
    BMC Nephrol; 2023 Dec; 24(1):363. PubMed ID: 38066480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Polymorphisms and Kidney Stones Around the Globe: A Systematic Review and Meta-Analysis.
    Mohammadi A; Shabestari AN; Baghdadabad LZ; Khatami F; Reis LO; Pishkuhi MA; Kazem Aghamir SM
    Front Genet; 2022; 13():913908. PubMed ID: 35846117
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic polymorphisms as prognostic factors for recurrent kidney stones: A systematic review and meta-analysis.
    Atmoko W; Raharja PAR; Birowo P; Hamid ARAH; Taher A; Rasyid N
    PLoS One; 2021; 16(5):e0251235. PubMed ID: 33956883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in Understanding the Genetics of Calcium-Containing Nephrolithiasis.
    Sayer JA
    J Am Soc Nephrol; 2017 Mar; 28(3):748-759. PubMed ID: 27932479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ApaL1 urokinase and Taq1 vitamin D receptor gene polymorphisms in first-stone formers, recurrent stone formers, and controls in a Caucasian population.
    Aykan S; Tuken M; Gunes S; Akin Y; Ozturk M; Seyhan S; Yuruk E; Temiz MZ; Yılmaz AF; Nguyen DP
    Urolithiasis; 2016 Apr; 44(2):109-15. PubMed ID: 26275878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A whole genome SNP genotyping by DNA microarray and candidate gene association study for kidney stone disease.
    Rungroj N; Nettuwakul C; Sudtachat N; Praditsap O; Sawasdee N; Sritippayawan S; Chuawattana D; Yenchitsomanus PT
    BMC Med Genet; 2014 May; 15():50. PubMed ID: 24886237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase gene 3'-UTR T/C polymorphism is associated with malignancy and ESRD in idiopathic membranous nephropathy.
    Chen CH; Chen SY; Shu KH; Wen MC; Cheng CH; Wu MJ; Yu TM; Chuang YW; Tsai FJ
    Biomed Res Int; 2014; 2014():425095. PubMed ID: 24822208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of the urokinase gene 3'-UTR T/C polymorphism and susceptibility to urolithiasis.
    Li D; Liu J; Ren J; Yan L; Liu H; Xu Z
    Biomed Rep; 2013 May; 1(3):369-374. PubMed ID: 24648951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of calcium urolithiasis with urokinase P141L and 3'-UTR C>T polymorphisms in a Japanese population.
    Hagikura S; Wakai K; Kawai S; Goto Y; Naito M; Hagikura M; Gotoh M; Hamajima N
    Urolithiasis; 2013 Feb; 41(1):47-52. PubMed ID: 23532423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predisposition of genetic polymorphism with the risk of urolithiasis.
    Mittal RD; Bid HK; Manchanda PK; Kapoor R
    Indian J Clin Biochem; 2008 Apr; 23(2):106-16. PubMed ID: 23105735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A microRNA-7 binding site polymorphism in HOXB5 leads to differential gene expression in bladder cancer.
    Luo J; Cai Q; Wang W; Huang H; Zeng H; He W; Deng W; Yu H; Chan E; Ng CF; Huang J; Lin T
    PLoS One; 2012; 7(6):e40127. PubMed ID: 22768238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the genetics of nephrolithiasis.
    Vezzoli G; Arcidiacono T; Paloschi V; Terranegra A; Biasion R; Soldati L
    Clin Cases Miner Bone Metab; 2008 May; 5(2):110-3. PubMed ID: 22460991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1β, calcium-sensing receptor, and urokinase gene polymorphisms in korean patients with urolithiasis.
    Kim JY; Kim YS; Chang IH; Kim TH; Kim HR
    Korean J Urol; 2011 May; 52(5):340-4. PubMed ID: 21687394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance.
    Mishra PJ; Humeniuk R; Mishra PJ; Longo-Sorbello GS; Banerjee D; Bertino JR
    Proc Natl Acad Sci U S A; 2007 Aug; 104(33):13513-8. PubMed ID: 17686970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urokinase gene 3'-UTR T/C polymorphism is associated with urolithiasis.
    Tsai FJ; Lin CC; Lu HF; Chen HY; Chen WC
    Urology; 2002 Mar; 59(3):458-61. PubMed ID: 11880102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of urokinase gene 3'-UTR T/C polymorphism with calcium oxalate urolithiasis in children.
    Ozturk M; Kordan Y; Cangul H; Dogan HS; Kilicarslan H; Vuruskan H; Oktay B
    Int Urol Nephrol; 2008; 40(3):563-8. PubMed ID: 18240004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of urokinase gene 3'-UTR polymorphism with calcium oxalate nephrolithiasis.
    Mittal RD; Bid HK; Kumar A; Bhandari M
    J Endourol; 2006 Feb; 20(2):157-60. PubMed ID: 16509805
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.